Philippe Beutels

Q: What Schools Are Affiliated With Philippe Beutels

Philippe Beutels is affiliated with the following schools: Université Laval, Hasselt University, University of Antwerp, University of New South Wales, University of Sydney

Philippe Beutels's AcademicInfluence.com Rankings

Philippe Beutels

Philosophy

#8802

World Rank

#12254

Historical Rank

Logic

#5820

World Rank

#7260

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Philippe Beutels's Degrees

Masters Public Health University of Antwerp

Why Is Philippe Beutels Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Philippe Beutels's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases (2008) (2491)
Rotavirus disease and vaccination: impact on genotype diversity. (2009) (296)
Global burden of disease (GBD) for hepatitis C (2004) (291)
Dynamic Epidemiological Models for Dengue Transmission: A Systematic Review of Structural Approaches (2012) (272)
Precautionary Behavior in Response to Perceived Threat of Pandemic Influenza (2007) (243)
Behavioural change models for infectious disease transmission: a systematic review (2010–2015) (2016) (235)
WHO Guide for standardisation of economic evaluations of immunization programmes. (2010) (207)
Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries (2009) (200)
Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis. (2019) (164)
The possible macroeconomic impact on the UK of an influenza pandemic. (2010) (163)
The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases (2015) (162)
Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment (2011) (161)
Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020 (2020) (150)
The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands (2010) (150)
Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models (2011) (144)
Cost-effectiveness analyses of human papillomavirus vaccination. (2007) (142)
Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). (2001) (133)
Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. (2001) (127)
Social mixing patterns for transmission models of close contact infections: exploring self-evaluation and diary-based data collection through a web-based interface (2006) (126)
Modeling Infectious Disease Parameters Based on Serological and Social Contact Data (2012) (123)
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. (2009) (122)
Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection (2007) (118)
Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium (2009) (116)
Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015) (2017) (112)
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis (2022) (110)
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). (2007) (110)
Estimating infectious disease parameters from data on social contacts and serological status (2009) (108)
Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review (2013) (108)
Costs and benefits of routine varicella vaccination in German children. (1996) (106)
The economic impact of SARS in Beijing, China (2009) (97)
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community (2015) (95)
The Burden of Rotavirus Acute Gastroenteritis in Europe (2010) (95)
Seventy-five years of estimating the force of infection from current status data (2009) (92)
Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group (2004) (88)
Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006). (2007) (83)
Economic Evaluations of Varicella Vaccination Programmes (2003) (81)
Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group (2017) (79)
Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella. (2009) (76)
A Nice Day for an Infection? Weather Conditions and Social Contact Patterns Relevant to Influenza Transmission (2012) (74)
A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact Infections (2019) (70)
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. (2002) (69)
Living on Three Time Scales: The Dynamics of Plasma Cell and Antibody Populations Illustrated for Hepatitis A Virus (2012) (68)
A systematic review of social contact surveys to inform transmission models of close contact infections (2018) (68)
Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern. (2008) (65)
The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis (2018) (65)
CoMix: comparing mixing patterns in the Belgian population during and after lockdown (2020) (64)
Mathematical models for assessment of long‐term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines (2000) (64)
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium: a prospective cross-sectional study of residual samples (2020) (63)
The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness. (2016) (63)
Funding of drugs: do vaccines warrant a different approach? (2008) (62)
Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium (2009) (62)
The health and economic burden of chickenpox and herpes zoster in Belgium (2012) (62)
Modelling age‐dependent force of infection from prevalence data using fractional polynomials (2006) (61)
A look into the future of the COVID-19 pandemic in Europe: an expert consultation (2021) (61)
COVID-19 and retail: The catalyst for e-commerce in Belgium? (2021) (60)
Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium (2009) (60)
Methodological issues and new developments in the economic evaluation of vaccines (2003) (60)
Hepatitis B prevention in Europe: a preliminary economic evaluation. (1995) (60)
Economic Evaluation of Vaccination Programmes (2002) (58)
Reviewing the Cost Effectiveness of Rotavirus Vaccination (2012) (57)
SOCRATES: an online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19 (2020) (57)
The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium) (2002) (57)
Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment. (2015) (56)
The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19 (2020) (54)
Estimating the Incidence of Symptomatic Rotavirus Infections: A Systematic Review and Meta-Analysis (2009) (53)
Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories (2020) (53)
Costing Infectious Disease Outbreaks for Economic Evaluation (2012) (53)
Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium (2010) (52)
The cost-effectiveness of rotavirus vaccination in Australia. (2007) (51)
Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives. (2018) (49)
Determinants of between-country differences in ambulatory antibiotic use and antibiotic resistance in Europe: a longitudinal observational study. (2014) (48)
Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. (2014) (47)
Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. (2015) (47)
Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006-2014). (2015) (46)
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". (2010) (46)
An economic evaluation of varicella vaccination in Italian adolescents. (2004) (45)
Global and Regional Burden of Hospital Admissions for Pneumonia in Older Adults: A Systematic Review and Meta-Analysis. (2019) (45)
Childhood varicella-zoster virus vaccination in Belgium: Cost-effective only in the long run or without exogenous boosting? (2013) (44)
Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All (2014) (42)
A simple periodic-forced model for dengue fitted to incidence data in Singapore. (2013) (42)
Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014. (2016) (42)
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies (2013) (41)
Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood. (2019) (39)
Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: a multi-country analysis for influenza A/H1N1v 2009. (2011) (38)
Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. (2020) (37)
Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. (2020) (37)
A Systematic Review of Clinical Practice Guidelines for the Diagnosis and Management of Bronchiolitis. (2020) (36)
An economic evaluation of universal pertussis vaccination in Italy. (1999) (36)
Economic evaluations of varicella vaccination programmes: a review of the literature. (2003) (36)
Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium). (2011) (36)
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries (2020) (36)
Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster (2015) (35)
Estimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife Infections (2016) (35)
Varicella vaccination in Australia (2005) (35)
Guidelines for multi-model comparisons of the impact of infectious disease interventions (2019) (34)
Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents. (2011) (33)
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease (2014) (33)
The health and economic burden of rotavirus disease in Belgium (2008) (32)
Modelling forces of infection by using monotone local polynomials (2003) (32)
Health‐related quality of life in patients with melanoma expressed as utilities and disability weights (2014) (31)
Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country (2003) (31)
Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders. (2018) (30)
Resurgence risk for measles, mumps and rubella in France in 2018 and 2020 (2018) (30)
Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination. (2004) (30)
A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies (2020) (29)
On discounting of health gains from human papillomavirus vaccination: effects of different approaches. (2012) (29)
Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). (2004) (29)
Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. (2012) (29)
Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox (2017) (29)
Universal hepatitis B vaccination in Belgium (2013) (28)
Economic evaluations applied to HB vaccination: general observations. (1998) (28)
Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population. (2014) (28)
The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in Europe. (2015) (28)
The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium (2013) (28)
Serology indicates cytomegalovirus infection is associated with varicella‐zoster virus reactivation (2014) (28)
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice? (2012) (27)
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. (2022) (27)
Influence of Frequent Infectious Exposures on General and Varicella-Zoster Virus-Specific Immune Responses in Pediatricians (2014) (27)
Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19 (2010) (27)
The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium. (2016) (27)
SOCRATES-CoMix: a platform for timely and open-source contact mixing data during and in between COVID-19 surges and interventions in over 20 European countries (2021) (27)
Household members do not contact each other at random: implications for infectious disease modelling (2017) (27)
Active Learning to Understand Infectious Disease Models and Improve Policy Making (2014) (27)
Consumer choice between common generic and brand medicines in a country with a small generic market. (2015) (26)
Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013. (2015) (26)
The role of economic evaluation in vaccine decision making (2012) (26)
Drivers of vaccine decision-making in South Africa: A discrete choice experiment. (2019) (25)
Preferential differences in vaccination decision-making for oneself or one’s child in The Netherlands: a discrete choice experiment (2020) (25)
Estimating the population prevalence and force of infection directly from antibody titres (2012) (25)
An economic evaluation of hepatitis A vaccination in Dutch military personnel. (1998) (25)
Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Atypical Nevi (2014) (25)
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008. (2009) (25)
Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses. (2014) (25)
Patient and prescriber determinants for the choice between amoxicillin and broader-spectrum antibiotics: a nationwide prescription-level analysis. (2013) (25)
A brief history of economic evaluation for human papillomavirus vaccination policy. (2010) (24)
Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis. (2011) (24)
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis (2020) (24)
Economic Evaluations of Childhood Influenza Vaccination (2012) (24)
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases. (2004) (24)
Towards a European strategy to address the COVID-19 pandemic (2021) (24)
Vaccination Policy and Ethical Challenges Posed by Herd Immunity, Suboptimal Uptake and Subgroup Targeting (2011) (24)
Kicking against the pricks: vaccine sceptics have a different social orientation. (2014) (23)
Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data. (2014) (23)
Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. (2017) (22)
Modelling multisera data: The estimation of new joint and conditional epidemiological parameters (2008) (22)
The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium). (2002) (22)
POTENTIAL IMPACT OF POLICY REGULATION AND GENERIC COMPETITION ON SALES OF CHOLESTEROL LOWERING MEDICATION, ANTIDEPRESSANTS AND ACID BLOCKING AGENTS IN BELGIUM (2012) (21)
Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets. (2020) (21)
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July–December 2020) (2021) (21)
The cost of measles in industrialised countries. (2003) (20)
Memory CD4+ T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus (2018) (20)
Varicella-Zoster Virus-Derived Major Histocompatibility Complex Class I-Restricted Peptide Affinity Is a Determining Factor in the HLA Risk Profile for the Development of Postherpetic Neuralgia (2014) (20)
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools (2011) (19)
Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium (2018) (19)
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol (2018) (19)
The macroeconomic costs of a global influenza pandemic (2008) (19)
Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virus (2008) (19)
Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability (2013) (19)
Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis a patients. (2011) (19)
POLYMOD social contact data (2017) (19)
How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018 (2020) (18)
Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium. (2014) (18)
Cost-effectiveness of hepatitis A vaccination in Indonesia (2014) (18)
The Sexual Ethics of HPV Vaccination for Boys (2014) (18)
Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic (2021) (18)
Melanoma burden by melanoma stage: Assessment through a disease transition model. (2016) (17)
Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical. (2016) (17)
Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study. (2013) (17)
Economic evaluations of adult pneumococcal vaccination strategies (2001) (17)
Evaluatie van universele en doelgroep hepatitis A vaccinatie opties in België = Evaluation of universal and targeted hepatitis A vaccination programs in Belgium (2008) (17)
Close contact infection dynamics over time: insights from a second large-scale social contact survey in Flanders, Belgium, in 2010-2011 (2020) (17)
The Cost of Arbovirus Disease Prevention in Europe: Area-Wide Integrated Control of Tiger Mosquito, Aedes albopictus, in Emilia-Romagna, Northern Italy (2017) (17)
Economic aspects of pneumococcal pneumonia: a review of the literature. (2004) (16)
Economic evaluation of vaccination programmes in humans: a methodological exploration with applications to hepatitis B, varicella-zoster, measles, pertussis, hepatitis A and pneumococcal vaccination (2002) (16)
Community-acquired pneumonia (CAP) hospitalizations and deaths: is there a role for quality improvement through inter-hospital comparisons? (2016) (15)
Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination. (1996) (15)
Estimating the impact of vaccination using age–time-dependent incidence rates of hepatitis B (2007) (15)
Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis. (2019) (15)
Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians. (2017) (14)
Data mining for longitudinal data under multicollinearity and time dependence using penalized generalized estimating equations (2012) (14)
Cost-effectiveness of hepatitis A vaccination for adults in Belgium. (2012) (14)
Optimizing agent-based transmission models for infectious diseases (2015) (14)
Belgian population norms for the EQ-5D-5L, 2018 (2021) (14)
Economic Aspects of Pneumococcal Pneumonia (2012) (13)
Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium? (2020) (13)
Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country (2020) (13)
Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation (2013) (13)
Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives. (2014) (13)
A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? (2018) (13)
Seasonal influenza vaccination: prioritizing children or other target groups? Part 2 : cost-effectiveness analysis (2013) (13)
Common attitudes about concomitant vaccine injections for infants and adolescents in Flanders, Belgium. (2009) (13)
The impact of non-financial and financial encouragements on participation in non school-based human papillomavirus vaccination: a retrospective cohort study (2016) (12)
Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study (2021) (12)
Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium (2016) (12)
In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease. (2020) (12)
Taking a COVID-19 Vaccine or Not? Do Trust in Government and Trust in Experts Help Us to Understand Vaccination Intention? (2022) (12)
Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective. (2020) (12)
Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds. (2015) (12)
Cytomegalovirus seropositivity is associated with herpes zoster (2015) (12)
Cost-effectiveness analysis of rotavirus vaccination of Belgian infants (2007) (12)
Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases (2015) (12)
Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges (2016) (11)
Clustering of susceptible individuals within households can drive measles outbreaks: an individual-based model exploration (2019) (11)
Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course (2020) (11)
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study (2022) (11)
Valuing prevention through economic evaluation (2012) (11)
Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: costeffectiveness analyses and implications for The Netherlands (2003) (11)
The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT. (2010) (11)
The disease burden of hepatitis B in Uzbekistan. (2000) (11)
Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood (2011) (11)
Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy. (2016) (10)
Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination. (2020) (10)
Estimation of the Force of Infection from Current Status Data Using Generalized Linear Mixed Models (2007) (10)
Cost analysis in favor of a combined approach for cytomegalovirus after kidney transplantation: a single‐center experience (2013) (10)
Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. (2018) (10)
Economic Evaluation of Vaccination (2012) (10)
Structural differences in mixing behavior informing the role of asymptomatic infection and testing symptom heritability. (2017) (9)
Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium. (2016) (9)
Inferring rubella outbreak risk from seroprevalence data in Belgium. (2016) (9)
Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression (2017) (9)
Cost-utility of vaccination against chickenpox in children and against herpes zoster in elderly in Belgium (2010) (9)
Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon (2020) (9)
Effects and costs of universal infant pneumococcal conjugate vaccination in Belgium (2006) (9)
Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus (2021) (8)
Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants. (2020) (8)
Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients (2021) (8)
Estimating vaccination coverage for the trivalent measles–mumps–rubella vaccine from trivariate serological data (2012) (8)
The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium (2017) (8)
Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population study (2015) (8)
Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study. (2020) (8)
The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic (2021) (8)
Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination (2018) (8)
The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia. (2018) (8)
Comments on the Prosser et al Approach to Value Disease Reduction in Children (2004) (8)
Effectiveness of a Malaria Surveillance Strategy Based on Active Case Detection during High Transmission Season in the Peruvian Amazon (2018) (8)
Hepatitis B in St Petersburg, Russia (1994–1999): incidence, prevalence and force of infection (2003) (8)
Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective. (2021) (8)
Effectiveness of seven-valent pneumococcal conjugate vaccine (2007) (7)
Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity (2018) (7)
Indications for healthcare surge capacity in European countries facing an exponential increase in COVID19 cases (2020) (7)
Recent quantitative research on determinants of health in high income countries: A scoping review (2020) (7)
Modelling distortions in seroprevalence data using change-point fractional polynomials (2010) (7)
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models (2020) (7)
Adaptive change-point mixed models applied to data on outpatient tetracycline use in Europe (2013) (6)
Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data (2021) (6)
No Such Thing as a Free-Rider? Understanding Drivers of Childhood and Adult Vaccination through a Multicountry Discrete Choice Experiment (2021) (6)
Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020 (2022) (5)
Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU). (2020) (5)
CAREGIVERS’ WILLINGNESS TO PAY TO REDUCE THE NUMBER OF VACCINE INJECTIONS IN INFANTS (2009) (5)
Cost-Effectiveness of Socioeconomic Support as Part of HIV Care for the Poor in an Urban Community-Based Antiretroviral Program in Uganda (2014) (5)
[Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders]. (2013) (5)
Do costs of varicella justify routine infant vaccination? (2004) (5)
COVID-19 Vaccine Prioritisation in Japan and South Korea (2021) (4)
[Pharmaco-economic aspects of vaccination against invasive pneumococcal infections in persons over 65 years of age; review of the literature on cost effectiveness analysis]. (2002) (4)
Zoster in monasteries: some clarification needed. (2012) (4)
[Varicella-zoster virus seroprevalence in nursery and day-care workers in Lyon (France)]. (2005) (4)
A trial like ALIC 4 E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? (2018) (4)
Supplementary material from "Behavioural change models for infectious disease transmission: a systematic review (2010–2015)" (2016) (4)
The health and economic impact of acute gastroenteritis in Belgium, 2010–2014 (2019) (4)
A spatial model to optimise predictions of COVID-19 incidence risk in Belgium using symptoms as reported in a large-scale online survey (2020) (4)
Program evaluation of universal varicella vaccination in Belgium: preliminary results (2000) (4)
Correction: Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases (2016) (4)
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial (2021) (4)
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon vaccination (2020) (4)
An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix. (2019) (4)
Unveiling the Risk Period for Death After Respiratory Syncytial Virus Illness in Young Children Using a Self-Controlled Case Series Design. (2020) (4)
Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016–2019 (2021) (3)
Séroprévalence de l'immunité au virus de la varicelle et du zona chez le personnel de crèche et de halte-garderie à Lyon (France) (2005) (3)
Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV (2022) (3)
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine (2022) (3)
Cost Analysis of Immunotherapy Using Dendritic Cells for Acute Myeloid Leukemia Patients (2014) (3)
Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature. The Authors’ Reply (2004) (3)
Response to comment on article by Jit et al. The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe (2011) (3)
Evolution over time in the cost-effectiveness of pneumococcal conjugate vaccine (PCV13) in older Australians due to herd protection from infant vaccination. (2018) (3)
Quantitative research on health determinants in high-income countries: Systematic literature review (2019) (3)
A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations (2020) (3)
Medicine price awareness in chronic patients in Belgium. (2015) (3)
Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom (2021) (3)
ECONOMIC EVALUATIONS OF PNEUMOCOCCAL VACCINATION STRATEGIES IN ADULTS. A SUMMARY OF THE RESULTS. (2005) (3)
Value Frameworks for Vaccines: Which Dimensions Are Most Relevant? (2020) (3)
Evolutions in Both Co-Payment and Generic Market Share for Common Medication in the Belgian Reference Pricing System (2013) (3)
Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens (2018) (3)
Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom (2021) (3)
Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness. (2021) (2)
Cost-Effectiveness of Hepatitis a Vaccination in Indonesia. (2014) (2)
An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix compared to Varilrix (2018) (2)
Social Contact Rates (SOCRATES) Data Tool (2020) (2)
Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel) (2020) (2)
Aggregate Wellbeing as Foundation to Discourage Childhood Chickenpox Vaccination (2020) (2)
Cost Effectiveness of Alternative Hepatitis A Immunisation Strategies (1995) (2)
What counts in cytometric analysis to document vaccine immunogenicity? (2012) (2)
No such thing as a free-rider? Understanding multicountry drivers of childhood and adult vaccination (2020) (2)
Care-seeking behaviour and socio-economic burden associated with uncomplicated malaria in the Democratic Republic of Congo (2021) (2)
Estimating the Force of Infection from Incidence and Prevalence (2012) (2)
Evaluations économiques de la vaccination pneumococcique : Analyse critique (1998) (2)
Social preferences for adopting new vaccines in the national immunization program: A discrete choice experiment. (2022) (2)
Pregnancy during COVID-19: social contact patterns and vaccine coverage of pregnant women from CoMix in 19 European countries (2022) (2)
UK experience of herpes zoster vaccination can inform varicella zoster virus policies. (2017) (2)
Economic evaluation of childhood vaccines (2009) (2)
Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop. (2014) (2)
Hepatitis A vaccine for secondary hepatitis A infection (1999) (2)
Streptococcus pneumoniae serotypes carried by young children and their association with Acute Otitis Media during the period 2016 – 2019 (2020) (2)
Sampling Site Matters When Counting Lymphocyte Subpopulations (2012) (2)
Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older Adults. (2022) (2)
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. (2011) (2)
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination (2022) (2)
Belgian population norms for the EQ-5D-5L, 2013 and 2018 (2020) (2)
Social contact patterns during the COVID-19 pandemic in 21 European countries – evidence from a two-year study (2022) (2)
Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2 (2022) (1)
Cost-effectiveness of varicella and zoster vaccination in England&Wales: importance measures for correlated parameters (2010) (1)
Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children. (2022) (1)
Nonparametric Approaches to Model the Prevalence and Force of Infection (2012) (1)
Protecting European health care workers against hepatitis B: a preliminary economic evaluation (1995) (1)
Transcriptomic profiling of different responder types in adults after a Priorix® vaccination. (2020) (1)
PIN16 COMPARATIVE CRITICAL REVIEW OF COST-EFFECTIVENESS TOOLS OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV) (2010) (1)
Economic evaluation in travel medicine (1997) (1)
Costs of management of acute respiratory infections in older adults: A systematic review and meta-analysis (2022) (1)
Lyme borreliosis in Belgium: a cost-of-illness analysis (2022) (1)
Cost-effectiveness of hepatitis B vaccination in low-endemic countries (1997) (1)
Social contact data from CoMix survey (Belgium) (2020) (1)
Links Between Herpes Zoster Incidence and Childhood Varicella Vaccination (2014) (1)
Assumptions were confusing (1995) (1)
The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence (2019) (1)
[Economic evaluations of pneumococcal vaccination. A critical analysis]. (1998) (1)
Priority-Setting and Personality: Effects of Dispositional Optimism on Preferences for Allocating Healthcare Resources (2019) (1)
Environmental triggers of acute myocardial infarction: does air pollution matter? (2013) (1)
Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice (2021) (1)
Social contact and mixing patterns relevant to the spread of infectious diseases: a multi-country population-based survey (2007) (1)
Long-term persistence of anti-HAV antibodies: model-based calculations of long-term persistence of anti-HAV antibodies after vaccination (1997) (1)
Cs SEASONAL INFLUENZA VACCINATION : PRIORITIZING CHILDREN OR OTHER TARGET GROUPS ? PART II : COST-EFFECTIVENESS ANALYSIS – SYNTHESIS (2013) (1)
Physicians Poster SessionsPoster Session / Day 1 (2015) (1)
Cost-effectiveness of respiratory syncytial virus preventive interventions in children: a model comparison study. (2022) (1)
Author Correction: Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox (2018) (1)
COL 2-03 - Le risque de résurgence de la rougeole, des oreillons et de la rubéole en France en 2016 (2016) (1)
SOCRATES: an online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19 (2020) (1)
The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study (2022) (1)
Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin (2015) (1)
Economic aspects of vaccines and vaccination: a global perspective (2005) (1)
The SIR Model (2012) (1)
Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin (2015) (1)
The Constraint of Monotonicity (2012) (1)
Evidence-based prevention of cannabis use in flanders is there a role for health economic evaluation? (2010) (1)
'Egocentric' Vaccination: The Authors Reply. (2016) (1)
Using an adaptive trial design for an infectious disease in primacy care - challenges in the design and set-up stages (2015) (1)
Modeling Multivariate Serological Data (2012) (0)
Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries. (2023) (0)
Correction (2014) (0)
Universal chickenpox vaccination of infants may be cost-saving to society, but better studies are needed (2003) (0)
PIN29 ECONOMIC EVALUATION OF MENINGOCOCCAL C VACCINATION PROGRAMMES AND ITS IMPACT ON DECISION MAKING (2004) (0)
Characterization of the treatment trajectory and assessment of the disease weight during uncomplicated malaria in the Democratic Republic of Congo (2019) (0)
Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon (2020) (0)
Corrigendum to "Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy" [Eur J Cancer 67 (2016) 38-45]. (2017) (0)
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries. (2022) (0)
S0950268821002569jra 1..7 (2022) (0)
Exponential-family random graph models for within-household contact networks (2014) (0)
Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games (2022) (0)
Optimizing agent-based transmission models for infectious diseases (2015) (0)
PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination: Findings from a Literature Review (2011) (0)
Pharmacoeconomics 2004; 22 (18): 1171-1179 (2004) (0)
Who Acquires Infection from Whom? The Traditional Approach (2012) (0)
Prevention of hepatitis A: economic aspects (1995) (0)
Integrating mathematical modeling, computational thinking and ICT applications (2008) (0)
Authors’ Reply to Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” (2022) (0)
A spatial model to jointly analyze self‐reported survey data of COVID‐19 symptoms and official COVID‐19 incidence data (2022) (0)
The Lancet Regional Health-Europe (2021) (0)
Cost analysis of dendritic cell therapy for acute myeloid leukemia patients (2015) (0)
Corrigendum to 'Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives' Soc. Sci. Med. 207 (2018) 106-116. (2018) (0)
[Splenectomy and pneumococcal vaccination]. (2003) (0)
Data Sources for Modeling Infectious Diseases (2012) (0)
Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project (2022) (0)
Do contacts over distance follow a power-law distribution? Estimation of the social contact distance kernel (2015) (0)
Histogram of the estimated extra costs of sequential digital dermoscopy imaging versus optical dermoscopy. (2014) (0)
Epidémie d'Ebola: une réponse internationale qui bafouille (2014) (0)
COL 09-01 - Facteurs socio-démographiques influant la propagation d’une épidémie : utilisation des données de contact (2013) (0)
Community Acquired Pneumonia (CAP) hospitalisations and deaths: is there a quality improvement role for inter-hospital comparisons? (2015) (0)
Ceci n'est pas un lit. Base capacity healthcare matters in a pandemic (2021) (0)
Modeling the Prevalence and the Force of Infection Directly from Antibody Levels (2012) (0)
[Not Available]. (2016) (0)
Avis et attitudes des pharmaciens et des mÃ©decins gÃ©nÃ©ralistes vis-Ã -vis de la prescription en DCI : enquÃªte rÃ©alisÃ©e Ã Anvers et en Flandre Orientale (2013) (0)
Catching the risk of measles outbreaks in a clustered society (2017) (0)
EE622 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention Interventions in Children: A Model Comparison Study (2022) (0)
Informing WAIFW with Data on Social Contacts (2012) (0)
Author Correction: Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox (2018) (0)
Computational Statistics and Data Analysis Data mining for longitudinal data under multicollinearity and time dependence using penalized generalized estimating equations ✩ (2015) (0)
Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022 (2022) (0)
INDIVIDUAL-BASED MODELS: POWERFUL OR POWER STRUGGLE? (2015) (0)
Economic Evaluation of Vaccination ProgrammesStatement Focusing on Viral Hepatitis (2002) (0)
Author response: Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster (2015) (0)
Priority-Setting and Personality: Effects of Dispositional Optimism on Preferences for Allocating Healthcare Resources (2019) (0)
Care-seeking behaviour and socio-economic burden associated with uncomplicated malaria in the Democratic Republic of Congo (2021) (0)
Memory CD4+ T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus (2018) (0)
What hinders general practitioners to prescribe cheaper? The use of International Non-proprietary Name (INN) in Belgium (2014) (0)
The future’s so bright, I gotta wear sunscreen: Dispositional optimism and preferences for prioritizing health care (2015) (0)
Not as easy as it sounds: Challenges in assessing the value for money of implemented vaccination programs (2014) (0)
The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan (2021) (0)
Revealing age-specific past and future unrelated costs of pneumococcal infections by flexible generalized estimating equations (2011) (0)
Determinants of basic childhood vaccination coverage in European and OECD countries (2022) (0)
Acknowledgement to Referees (2017) (0)
The disability adjusted life years (DALYs) and economic burden due to haemophilia in Belgium (2014) (0)
Economic Impact of Influenza: The Macro Perspective (2007) (0)
Hierarchical Nonparametric Bayesian Models for the Force of Infection for Mumps and Rubella (0)
Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK (2021) (0)
How can early stage economic evaluation help guide research for future vaccines? (2021) (0)
Multi-view learning to unravel the different levels underlying hepatitis B vaccine response (2023) (0)
Partially Wrong? Partial Equilibrium and the Economic Analysis of Infectious Disease Interventions (2007) (0)
Why This Book? An Introduction (2012) (0)
The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic (2022) (0)
The estimated disease burden of COVID-19 in Japan from 2020 to 2021 (2022) (0)
The Sexual Ethics of HPV Vaccination for Boys (2013) (0)
Placing a value on increased flexible vaccine manufacturing capacity for future pandemics (2023) (0)
Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies (2023) (0)
Safe water or hepatitis B vaccination in India: general comments (1999) (0)
A Priori and A Posteriori Models for Infectious Diseases (2012) (0)
Cervical cancer screening based on urine self-sampling to reach un(der)-screened women: study protocol of the ScreenUrSelf trial (2023) (0)
PIN25 EXPLORATORY ANALYSIS OF THE ECONOMICALLY JUSTIFIABLE PRICE OF AN RSV VACCINE FOR THE ELDERLY IN THE NETHERLANDS AND THE UNITED KINGDOM (2019) (0)
Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity (2017) (0)
Opinions and attitudes of pharmacists and general physicians towards INN presscribing in Flanders (2013) (0)
Estimating transmission parameters using social contact data and serological data. (2008) (0)
Exploring human mixing patterns based on time use and social contact data and their implications for infectious disease transmission models (2022) (0)
Universele hepatitis B-vaccinatie in Vlaanderen (2000) (0)
Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa (2022) (0)
Estimating Age-Time Dependent Prevalence and Force of Infection from Serial Prevalence Data (2012) (0)
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe. (2023) (0)
Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. (2019) (0)
Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018) (2023) (0)
Cannabispreventie te soft voor harde waarheid (2006) (0)
The in uence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic (2021) (0)
Hierarchical Bayesian Models for the Force of Infection (2012) (0)
Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands (2022) (0)
Preexisting memory CD 4 T cells in naïve individuals confer robust 1 immunity upon hepatitis B vaccination 2 Running title : Preexisting memory T cells confer immunity to vaccination 3 (2021) (0)
Integrating Estimated Parameters in a Basic SIR Model (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Philippe Beutels?

Philippe Beutels is affiliated with the following schools: